The quantitative detection of the abuse/intoxication of gamma-hydroxybutyric acid (GHB) also known as liquid ecstasy is still a challenge in toxicology.
To date, GHB is not detected by routine blood or urine drug screens. Its detection is virtually only possible with chromatographic methods. These methods are time-consuming and laborious since they often require derivatization of the drug and/or sample extraction. Therefore many cases involving GHB may be missed in hospitals and forensic institutes.
This situation causes a permanent under-estimation of the amount of this kind of severe intoxications or the inappropriate care of victims. Clearly, there is a requirement for simple and rapid analytical procedures to meet current increased demand for analysis.
The BÜHLMANN enzymatic GHB assay will allow a direct, quick and easy quantification of exogenous intake of GHB.
GHB Product Information
|Time to Result
||10 min (approx.)
||Urine / Serum <10 µl
|On-board Stability of Reagent
||Stable for 2 months at up to 15 °c
||US 8,609,359 B2; EP 2 253 711 B1; JP 5711216 B2
* Multilingual [EN, DE, FR, IT, ES]